The crystal structure of the activin B:Fst288 complex and computational insights into the broad antagonistic activity and specificity of follistatin
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.113459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Lucija Hok und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Follistatin, Activins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Members of the transforming growth factor-β (TGF-β) family regulate essential biological processes, and their activity is tightly controlled by extracellular antagonists like follistatin 288 (Fst288). While Fst288 potently inhibits several ligands, including activins A and B, GDF8, and GDF11, the structural basis for its interaction with activin B (ActB) has remained largely uncharacterized. This lack of data has limited our understanding of how Fst288 achieves such broad inhibitory activity while maintaining ligand-specific selectivity. In this study, we resolved the crystal structure of the ActB:Fst288 complex at 2.7 Å resolution. Our findings reveal that while Fst288 utilizes a conserved receptor-blocking mechanism, ActB engages the antagonist through a modified structural mode. Most notably, the fingertips of ActB form direct, unique contacts with the third follistatin domain (FSD3). This interaction disrupts the intermolecular head-to-tail cooperativity typically seen in Fst288 dimers, shifting the stabilization of the complex toward individual ligand-domain affinities. Computational analysis supports a model where ActB relies more on direct contacts with Fst288, whereas ActA relies on the intermolecular head-to-tail Fst288 interactions. Further computational analysis indicates ActB is more flexible than ActA and GDF8. These results suggest that Fst288's broad potency arises from a dynamic interplay between ligand flexibility and antagonist conformational plasticity that can accommodate different ligand surfaces. By elucidating unique characteristics of the ActB:Fst288 interface, this study deepens the understanding of ligand selectivity and provides a framework for the rational design of targeted TGF-β antagonists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Pharmacology & Systems Physiology, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA. Electronic address: Tom.Thompson@uc.edu.
Förderung
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Hok, L., Walker, R. G., Howard, J. A., Gouge, M. M., Mast, E. M., Kattamuri, C., Goebel, E. J., & Thompson, T. B. (2026). The crystal structure of the activin B:Fst288 complex and computational insights into the broad antagonistic activity and specificity of follistatin. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113459
Vancouver
Hok L, Walker RG, Howard JA, Gouge MM, Mast EM, Kattamuri C, et al. The crystal structure of the activin B:Fst288 complex and computational insights into the broad antagonistic activity and specificity of follistatin. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113459
BibTeX
@article{Hok2026,
author = {Hok, Lucija and Walker, Ryan G and Howard, James A and Gouge, Melissa M and Mast, Eleanor M and Kattamuri, Chandramohan and Goebel, Erich J and Thompson, Thomas B},
title = {The crystal structure of the activin B:Fst288 complex and computational insights into the broad antagonistic activity and specificity of follistatin},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.113459}
}
EUVIMED